Signaling pathways
-
BA4926 JAK-IN-26Summary: JAK-IN-26 is an orally active inhibitor with a favorable pharmacokinetic profile. - BA4927 JAK1-IN-13Summary: JAK1-IN-13 is an orally active, potent and highly selective inhibitor.
- BA4928 GDC-4379Summary: GDC-4379 is an inhibitor.
- BA4929 GS-829845Summary: GS-829845 is an inhibitor.
- BA4930 SD-1029Summary: SD-1029 is an inhibitor.
- BA4931 LepzacitinibSummary: Lepzacitinib is a Janus kinase inhibitor.
-
BA4932 RO495Summary: A potent inhibitor of non-receptor tyrosine protein kinase 2 (kinase). - BA4933 FosifidancitinibSummary: Fosifidancitinib is a potent and selective inhibitor of JAK kinase 1/3.
- BA4934 JAK-IN-21Summary: JAK-IN-21 is a selective and potent inhibitor.
- BA4935 MS-1020Summary: MS-1020 is a potent competitive inhibitor of ATP.